[Clinical efficiency in children treated with intravenous drip infusion of peramivir]

Hiroshi Sakata1

  • 1Department of Pediatrics, Asahikawa Kosei Hospital.

Insights

Peramivir effectively reduced fever in children with influenza, achieving defervescence faster than oseltamivir. This study highlights peramivir as a beneficial treatment option for pediatric influenza cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Influenza remains a significant respiratory illness in children.
  • Antiviral medications like oseltamivir are commonly used, but new treatment options are continually explored.
  • Peramivir, an intravenous neuraminidase inhibitor, offers a potential alternative for influenza treatment.

Purpose of the Study:

  • To retrospectively evaluate the clinical effectiveness of peramivir in pediatric patients with influenza.
  • To compare the time to defervescence between peramivir and oseltamivir treatment groups.
  • To assess the safety profile of peramivir in children.

Main Methods:

  • Retrospective analysis of 30 children treated with a single dose of intravenous peramivir (10 mg/kg).
  • Comparison with a historical cohort of 30 children treated with oseltamivir (4 mg/kg/day).
  • Primary endpoint: time from drug administration to defervescence (body temperature <37.5°C).

Main Results:

  • Significantly faster defervescence was observed in the peramivir group compared to the oseltamivir group (p<0.05).
  • 80% of patients in the peramivir group achieved defervescence within 24 hours.
  • One patient experienced elevated AST and ALT levels as an adverse reaction.

Conclusions:

  • Peramivir demonstrated significant clinical effectiveness in treating influenza in children, evidenced by rapid defervescence.
  • The study suggests peramivir is a safe and effective option for pediatric influenza.
  • Further research may explore peramivir's role in different pediatric populations and influenza strains.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...